Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finotonlimab (SCT-I10A) in Pre-treated Recurrent/Metastatic HNSCC
NCT04146181Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Oct 2019
- Primary completion
- Jun 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of finotonlimab in head and neck squamous cell carcinoma (HNSCC), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
finotonlimab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04146181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04146181.